|
|
|
|
Vol. 53, Issue 6, 1062-1067, June 1998
Departments of Pharmacology (R.A.M.H. van A., F.G.M.R.), Biochemistry (J.B.K.), and Cell Physiology (M.A. van K., P.M.T.D., C.H. van O.), University of Nijmegen, 6500 HB Nijmegen, The Netherlands
| |
Summary |
|---|
|
|
|---|
The multidrug resistance-associated protein Mrp2 is expressed in liver,
kidney, and small intestine and mediates ATP-dependent transport of
conjugated organic anions across the apical membrane of epithelial
cells. We recently cloned a rabbit cDNA encoding a protein that on
basis of highest amino acid homology and tissue distribution was
considered to be the rabbit homolog of rat Mrp2. To investigate whether
rabbit Mrp2 mediates ATP-dependent transport similar to rat Mrp2, we
expressed rabbit Mrp2 in Spodoptera frugiperda (Sf9)
cells using recombinant baculovirus. Mrp2 was expressed as an
underglycosylated protein in Sf9 cells and to a higher level compared
with rabbit liver and renal proximal tubules. Both
17
-estradiol-17-
-D-glucuronide ([3H]E217
G, 50 nM) and
[3H]leukotriene C4 (3 nM) were
taken up by Sf9-Mrp2 membrane vesicles in an ATP-dependent fashion.
Uptake of [3H]E217
G was dependent on the
osmolarity of the medium and saturable for ATP
(Km = 623 µM). Leukotriene
C4, MK571, phenolphthalein glucuronide, and
fluorescein-methotrexate were good inhibitors of
[3H]E217
G transport. The inhibitory
potency of cyclosporin A and methotrexate was moderate, whereas
fluorescein,
-naphthyl-
-D-glucuronide, and
p-nitrophenyl-
-D-glucuronide did not
inhibit transport. In conclusion, we show direct ATP-dependent
transport by recombinant rabbit Mrp2 and provide new data on Mrp2
inhibitor specificity.
| |
Introduction |
|---|
|
|
|---|
Elimination
of endogenous waste products and xenobiotics from the body is mediated
by renal and hepatic transport pathways. Excretion of anionic
conjugates across liver canalicular (apical) membranes into bile is
mediated by the multidrug resistance-associated protein MRP2
(Müller and Jansen, 1997
). Initially, this transporter was named
cMOAT and characterized by using natural mutant strains of Wistar
(TR
) and Sprague-Dawley (EHBR) rats
(Müller and Jansen, 1997
). Recently, cloning of rat Mrp2 revealed
that the impaired conjugate transport in canalicular membranes of these
rats is caused by a premature termination of the mrp2 gene
product (Paulusma et al., 1996
; Ito et
al., 1997
). Similarly, a mutation leading to a
truncated MRP2 was identified in a patient with Dubin-Johnson syndrome,
a disease that resembles the TR
phenotype
(Paulusma et al., 1997
).
Database analysis revealed that rat Mrp2 is strongly related to the
human multidrug resistance-associated protein MRP1, a member of the
superfamily of ABC proteins (Büchler et al.,
1996
; Paulusma et al., 1996
; Ito
et al., 1997
). Originally, MRP1 was identified
due to its overexpression in a multidrug-resistant cell line and its
ability to confer resistance to chemotherapeutic drugs (Loe et
al., 1996
). Using isolated membrane vesicles from MRP1-transfected cells, it has been shown that MRP1 is also
capable of transporting anionic conjugates in an ATP-dependent manner. Although MRP1 and MRP2 share substrate specificity, these transporters show differences in their tissue distribution. MRP1 is expressed, predominantly intracellularly, in numerous tissues such as lung, heart,
and kidney (Flens et al., 1996
). In contrast,
MRP2 was detected in small intestine and apical (canalicular) membranes of hepatocytes and cells of renal proximal tubules (Büchler
et al., 1996
; Paulusma et al.,
1996
; Schaub et al., 1997
).
We cloned a rabbit cDNA encoding an ABC-transporter that on basis of
similar tissue distribution and highest amino acid homology was
considered to be the rabbit homolog of rat Mrp2 (van Kuijck et
al., 1996
, 1997
). On injection of its cRNAs
in Xenopus laevis oocytes, we observed in a few cases a
cAMP-dependent chloride conductance (van Kuijck et al.,
1996
). To investigate whether rabbit Mrp2 functions as an
ATP-dependent organic anion transporter similar to rat Mrp2, we
expressed rabbit Mrp2 in Sf9 cells using recombinant baculovirus and
studied uptake of the anionic conjugates E217
G
and LTC4 into isolated membrane vesicles. In
addition, the effect of various inhibitors on Mrp2-mediated
[3H]E217
G transport
was investigated.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
[14,15,19,20-3H]LTC4 (165 Ci/mmol) and
[6,7-3H]E217
G (55 Ci/mmol) were purchased from NEN Life Science Products (Hoofddorp, The
Netherlands). ATP, 5'-AMP, LTC4,
E217
G, MTX, CsA,
-naphthyl-
-D-glucuronide, phenolphthalein
glucuronide, and p-nitrophenyl-
-D-glucuronide were purchased from Sigma (Zwijndrecht, The Netherlands). FL-MTX and FL
were purchased from Molecular Probes (Leiden, The Netherlands). Creatine phosphate and creatine kinase were purchased from
Boehringer-Mannheim (Almere, The Netherlands). CELLFECTIN and competent
DH10BAC Escherichia coli cells were purchased from Life
Technologies (Breda, The Netherlands). PNGase F was purchased from New
England Biolabs (Westburg, Leiden, The Netherlands). MK571 was a
generous gift of Dr. A. W. Ford-Hutchinson (Merck Frosst, Center
for Therapeutic Research, Quebec, Canada).
Preparation of antibodies.
Rabbit polyclonal antibodies were
directed against two different epitopes of rabbit Mrp2 (van Kuijck
et al., 1996
). Antiserum k78mrp2 was obtained by
immunizing rabbits with a glutathione-S-transferase fusion
protein containing the 159 carboxyl-terminal amino acids (1405-1564)
of Mrp2. Antiserum k51mrp2 was obtained by immunizing rabbits with a
synthetic peptide (FQKRQQKKSQKNSRLQGL) corresponding to amino acids
257-274 of Mrp2 coupled to keyhole limpet hemocyanin. Rabbits were
immunized with 400 µg of either the fusion protein or the synthetic
peptide mixed with Freund's complete adjuvants. At 3-week intervals
after priming, rabbits were boosted with 200 µg of proteins
supplemented with incomplete adjuvants. Test bleedings were checked for
the presence of Mrp2-specific antibodies using enzyme-linked
immunosorbent assay.
Expression construct.
The vector pFASTBAC1 (Life
Technologies) contains an expression cassette that consists of a
polyhedrin promoter, a multiple cloning site, and an SV40
poly(A)+ signal inserted between the left and
right arms of the bacterial transposon Tn7. Cloning of a rabbit mrp2
cDNA into pFASTBAC1 was accomplished in two steps: (1) from the
pBluescript KS+ construct pBSmrp2, which
contains the entire rabbit mrp2 coding sequence (nucleotides
347-5038) (van Kuijck et al., 1996
), a 2.7-kb XbaI/PstI fragment (nucleotides 2690-5407) was
cloned into the XbaI and PstI sites of the
multiple cloning site of pFASTBAC1 to create pFASTBAC-m1; and (2)
to minimize the 5'-untranslated region, the 5' coding sequence of
rabbit Mrp2 was amplified by polymerase chain reaction using the
forward primer Mrp2-F1 (5'-ATGCTGGATAAGTTCTGCAAC-3'; nucleotides 347-368), which contains the ATG start codon (underlined), and the reverse primer Mrp2-R1 (5'-GCAGGAGTAGGCCAGATTAG-3'; nucleotides 844-824). The resulting polymerase chain reaction product of 498 bp
was cloned into the SmaI site of pBluescript
KS+, and its sequence was verified by dideoxy
sequence analysis (Sanger et al., 1977
). From
this construct, a StyI/HincII fragment was removed and replaced by a StyI/EcoRV fragment
(nucleotides 480-3007) from pBSmrp2. Next, a 2.5-kb BamHI
fragment of this construct, containing the 5'-region of mrp2
(nucleotides 347-2868), was cloned into the BamHI site of
pFASTBAC1-m1, and its orientation was determined. The selected
construct, designated pFBmrp2, contains a full-length rabbit
mrp2 cDNA with the ATG start codon immediately downstream of
the polyhedrin promoter.
Production of recombinant baculovirus and viral infection.
Baculovirus encoding rabbit Mrp2 was generated using the Bac-to-Bac
baculovirus-expressing system (Life Technologies). Competent DH10BAC
E. coli cells harboring a baculovirus shuttle vector
(bacmid) with a Tn7 attachment site were transformed with the
pFBmrp2 construct. On transposition between the Tn7 sites,
recombinant bacmids were selected and isolated according to the
manufacturer. Subsequently, insect Sf9 cells were transfected with
recombinant bacmids using CELLFECTIN reagent. After 3 days, culture
medium was collected and used to infect fresh Sf9 cells. Four days
after infection, stocks of amplified virus were made. Sf9 cells
(106/ml) were grown as 100-ml suspension cultures
and infected at a multiplicity of infection of 1-5 with recombinant
baculovirus encoding Mrp2. For control experiments, Sf9 cells were
infected with recombinant baculovirus encoding
-glucuronidase (Life
Technologies) or the
-subunit of
H+/K+-ATPase (Klaassen
et al., 1993
). Three days after infection,
membrane fractions were isolated (see below).
Isolation of membrane fractions.
Crude membrane fractions
and membrane vesicles from infected Sf9 cells were isolated as
described by Leier et al. (1994)
with modifications. Briefly, cells were collected and resuspended in hypotonic buffer (0.5 mM sodium phosphate, 0.1 mM EDTA, pH 7.0) supplemented with protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 5 µg/ml aprotinin, 5 µg/ml leupeptin, 1 mM pepstatin). Cells were stirred
gently on ice for 90 min, and the resulting lysate was centrifuged at
100,000 × g for 40 min at 4°. The pellet of crude
membranes was resuspended in TS-buffer (10 mM Tris-HEPES, 250 mM sucrose, pH 7.4) using a Potter homogenizer, and the
homogenate was centrifuged at 12,000 × g for 10 min at
4°. The postnuclear supernatant was centrifuged at 100,000 × g for 40 min at 4°, and the pellet obtained was
resuspended in TS-buffer with a tight-fitting Dounce (type B)
homogenizer. The suspension was layered over 38% sucrose in 5 mM HEPES/KOH, pH 7.4, and centrifuged at 100,000 × g for 2 hr at 4°. The interphase was collected and
homogenized on ice with a tight-fitting Dounce (type B) homogenizer,
and the suspension was centrifuged at 100,000 × g for
40 min at 4°. The resulting pellet was resuspended in TS-buffer and
passed through a 27-gauge needle 30 times. Membrane vesicles were
frozen and stored at
80° until use. Sidedness of membrane vesicles
was assessed by measuring 5'-nucleotidase activity (Doige and Sharom,
1991
), and it was determined that ~65% of the vesicles were
orientated inside-out.
Deglycosylation studies and immunoblot analysis.
Crude
membrane fractions from Sf9 cells infected with Mrp2-encoding
baculovirus and from rabbit kidney were treated with PNGase F according
to the manufacturer. Protein-equivalents (see figure legends) were
solubilized in Laemmli's sample buffer supplemented with 100 mM dithiothreitol, heated for 10 min at 65°, subjected to
SDS-polyacrylamide gel electrophoresis, and transferred to Hybond-C
pure nitrocellulose membrane (Amersham, Buckinghamshire, UK) as
described previously (Deen et al., 1996
).
Transfer of proteins was confirmed by the reversible staining of the
membrane with Ponceau Red. Subsequently, the blot was blocked for 60 min with 5% nonfat dry milk powder in Tris-buffered saline
supplemented with 0.3% Tween-20 (TBS-T) and washed twice with TBS-T.
To detect rabbit Mrp2 proteins, the membrane was incubated overnight at 4° with antiserum k78mrp2 or k51mrp2 diluted 1:5000 in TBS-T. After
two times washing for 5 min with TBS-T, the blot was blocked for 30 min
as described above. The blot was then washed twice with TBS-T and
incubated at room temperature for 60 min with affinity-purified horseradish peroxidase-conjugated goat anti-rabbit IgG (Sigma Immunochemicals, St. Louis, MO) diluted 1:5000 in TBS-T. Finally, the
blot was washed twice for 5 min with TBS-T and TBS, respectively. Proteins were visualized using enhanced chemiluminescence (Pierce, Rockford, IL).
Transport studies in membrane vesicles.
Uptake of
[3H]LTC4 into membrane
vesicles was measured by using a rapid filtration technique (Leier
et al., 1994
). Briefly, membrane vesicles (20 µg protein-equivalent) were rapidly thawed and incubated at 37° in
the presence of 4 mM MgATP, 10 mM
MgCl2, 10 mM creatine phosphate, 100 µg/ml creatine kinase, and 3 nM [3H]LTC4 in a final
volume of 120 µl of TS-buffer (10 mM Tris-HEPES, 250 mM sucrose, pH 7.4). At indicated times, 20-µl samples
were taken from the reaction mixture, diluted in ice-cold TS-buffer and
filtered through nitrocellulose filters (0.45-µm pore size, Schleicher & Schuell, Dassel, Germany) using a filtration device (Millipore, Bedford, MA). Filters were washed once with 5 ml of TS-buffer and dissolved in liquid scintillation fluid to determine the
bound radioactivity. In control experiments, 4 mM MgATP was replaced by 4 mM 5'-AMP. Net ATP-dependent transport was
calculated by subtracting values in the presence of 5'-AMP from those
in the presence of ATP. Uptake of
[3H]E217
G at a final
concentration of 50 nM was done similarly as described for
[3H]LTC4, except that a
50 µg protein-equivalent of membrane vesicles was used.
| |
Results |
|---|
|
|
|---|
Sf9 insect cells were infected with recombinant baculovirus
encoding rabbit Mrp2 or control baculovirus. Crude membranes were prepared and subjected to immunoblot analysis using antiserum k78mrp2
and k51mrp2. Both antisera detected a protein of ~180 kDa in
membranes from cells infected with baculovirus encoding Mrp2 (Fig.
1A, Sf9-Mrp2) but not in membranes from
cells infected with control baculovirus (Fig. 1A, Sf9-c). This size is
smaller than cMoat/Mrp2 detected in liver and kidney, which has been
reported to have a molecular weight of ~190 kDa (Paulusma et
al., 1996
; Büchler et al.,
1996
; Schaub et al., 1997
). To
investigate whether this difference in molecular weight can be
attributed to differences in post-translational modifications, crude
membrane fractions from rabbit kidney and Sf9-Mrp2 cells were treated
with or without PNGase F and analyzed by immunoblotting using antiserum
k78mrp2 (Fig. 1B). Deglycosylation reduced the molecular weight of
rabbit kidney Mrp2 from ~190 to 175 kDa, which is the size that can
be deduced from the rabbit mrp2 cDNA sequence (van Kuijck
et al., 1996
, 1997
). Treatment with
PNGase F reduces the molecular mass of Mrp2 in Sf9 cells only slightly
to 175 kDa. This indicates that in Sf9 cells, Mrp2 is less glycosylated
than in rabbit kidney.
|
To determine the expression level of rabbit Mrp2 in Sf9 cells, we subjected crude membrane fractions from Sf9-Mrp2 cells and rabbit liver and rabbit renal proximal tubular cells to immunoblot analysis using antiserum k78mrp2 (Fig. 2). A 1 µg protein-equivalent of crude membranes from Sf9-Mrp2 cells was sufficient to detect Mrp2. Approximately 20 µg protein-equivalent of crude membranes from liver and renal proximal tubules was needed to detect a similar amount of Mrp2 protein as present in 4 µg protein-equivalent of Sf9-Mrp2 crude membranes.
|
To investigate whether recombinant rabbit Mrp2 is functional, we
investigated uptake of
[3H]LTC4 and
[3H]E217
G into
Sf9-Mrp2 and Sf9-c membrane vesicles. Sf9-Mrp2 membrane vesicles
exhibit net ATP-dependent uptake of both
[3H]LTC4 (Fig.
3, left) and
[3H]E217
G (Fig. 3,
right), which was at the 2-min time point ~11-fold higher
than in Sf9-c membrane vesicles. In the presence of 5'-AMP, transport
of either substrate was hardly detectable in Sf9-Mrp2 membrane vesicles
and was similar to that in Sf9-c membrane vesicles in the presence of
5'-AMP or ATP (not shown). Initial rates of uptake for 3 nM
[3H]LTC4 and 50 nM
[3H]E217
G were 75 and
450 fmol/mg/min, respectively.
|
To confirm that vesicle-associated increase of ligand reflects
transport into a vesicular space rather than aspecific binding to the
membrane, the medium osmolarity dependence of
[3H]E217
G uptake was
investigated. By increasing the extravesicular sucrose concentration
from 250 mM (isotonic condition) to 1000 mM,
membrane vesicle space will shrink resulting in decreased uptake. As
shown in Fig. 4A, initial rates of
[3H]E217
G uptake in
Sf9-Mrp2 membrane vesicles decreased linearly with increasing
concentrations of sucrose. Transport in Sf9-Mrp2 membrane vesicles
should also be dependent on the extravesicular concentration of ATP.
Fig. 4B shows that initial rates of
[3H]E217
G uptake
increased with ATP concentrations according to Michaelis-Menten
kinetics, yielding an apparent Km
value of 623 ± 131 µM and
Vmax value of 563 ± 32 fmol/mg/min.
|
To characterize the inhibitor specificity of rabbit Mrp2, we studied
the effect of various compounds on
[3H]E217
G uptake by
Sf9-Mrp2 membrane vesicles (Table 1).
Phenolphthalein glucuronide exerted a profound inhibition, whereas the
other two glucuronides (
-naphthyl-
-D-glucuronide,
p-nitrophenyl-
-D-glucuronide) and FL, a
substrate of the classic organic anion transport system (Sullivan
et al., 1990
), did not inhibit transport up to 1 mM. Uptake was also susceptible to inhibition by
LTC4, MTX, and FL-MTX. Furthermore, we tested the
LTD4-receptor antagonist MK571 (Jones et
al., 1989
) and the immunosuppressive agent CsA, both of
which are inhibitors of human MRP1 and rat Mrp2 (Leier et
al., 1994
; Büchler et al.,
1996
) and proved to be inhibitors of rabbit Mrp2.
|
| |
Discussion |
|---|
|
|
|---|
Mrp2 mediates ATP-dependent elimination of conjugated organic
anions from liver and has recently been cloned from rat (Büchler et al., 1996
; Paulusma et al.,
1996
; Ito et al., 1997
; Madon et al., 1997
) and human (Taniguchi et al.,
1996
; Paulusma et al., 1997
). We
cloned a rabbit cDNA encoding an ABC-transporter that on basis of
similar tissue distribution and highest amino acid homology was
considered as the rabbit homolog of rat Mrp2 (van Kuijck et
al., 1996
, 1997
). On injection of its cRNAs
in Xenopus laevis oocytes, we observed in a few cases a
cAMP-dependent chloride conductance (van Kuijck et al.,
1996
). The recent finding that substrates of Mrp2 activate a
chloride conductance in hepatocytes of normal rats but not in
TR
hepatocytes (Weinman and Carruth, 1997
)
indicates that this phenomenon warrants further investigation.
To investigate Mrp2-mediated transport, we expressed rabbit Mrp2 in Sf9
cells using recombinant baculovirus. In these cells, Mrp2 is highly
expressed, although less glycosylated compared with kidney Mrp2. This
is in line with results from other studies in which CFTR and MRP1 were
expressed in insect cells and detected as an underglycosylated product
(Kartner et al., 1991
; Gao et al.,
1996
). Results of functional studies on MRP1- and
CFTR-expressing insect cells are comparable to those obtained from
transfected eukaryotic cells, indicating that underglycosylation has no
significant effect on its function (Kartner et al.,
1991
; Gao et al., 1996
). This was
further corroborated by inhibition of glycosylation with tunicamycin in
drug-resistant MRP1-expressing human cells (Bakos et al.,
1996
) and, on basis of our studies, can also be concluded for Mrp2.
Based on studies with intact rats and liver canalicular membranes, the
conjugates E217
G and
LTC4 are considered to be substrates for rat Mrp2
(Büchler et al., 1996
; Takikawa et
al., 1996
). In addition, ATP-dependent transport of
LTC4 has been demonstrated in membrane vesicles
isolated from NIH/3T3 cells transfected with a rat mrp2
cDNA, and LTC4 efflux was found in
Mrp2-expressing Xenopus oocytes and COS-7 cells (Madon
et al., 1997
; Ito et al., 1998
). In the current study, we unambiguously demonstrated
that rabbit Mrp2 mediates ATP-dependent uptake of both
[3H]E217
G and
[3H]LTC4. The initial
uptake rates for [3H]LTC4
and [3H]E217
G, as well
as the Vmax value for ATP using
[3H]E217
G as a
cosubstrate, are lower than the values described for rat canalicular
membrane vesicles (Büchler et al., 1996
; Vore et al., 1996
) and membrane vesicles from
mrp2-transfected NIH/3T3 cells (Ito et al.,
1998
). This difference, however, may be explained by the
substantially lower substrate concentrations that we used. Uptake of
[3H]E217
G in Sf9-Mrp2
membrane vesicles was inhibited by LTC4 and phenolphthalein glucuronide.
-Naphthyl-
-D-glucuronide
and p-nitrophenyl-
-D-glucuronide had no
significant effect on uptake, although both compounds are thought to be
Mrp2 substrates. ATP-dependent uptake of
p-nitrophenyl-
-D-glucuronide into rat
canalicular membrane vesicles has been described, whereas in
TR
rat livers,
-naphthyl-
-D-glucuronide excretion was impaired (de
Vries et al., 1989
; Kobayashi et al.,
1991
). These findings suggest that
-naphthyl-
-D-glucuronide and
p-nitrophenyl-
-D-glucuronide are transported
with low affinity by Mrp2 and consequently are poor competitive
inhibitors themselves. MK571 and CsA are inhibitors of human MRP1 and
rat Mrp2 (Leier et al., 1994
; Büchler
et al., 1996
) and, as shown in this study, also
inhibit rabbit Mrp2-mediated [3H]E217
G transport.
However, it remains to be elucidated whether these compounds are Mrp2
substrates.
Mrp2 is expressed not only in liver canalicular membranes but also in
small intestine and brush-border membranes of renal proximal tubular
cells (Büchler et al., 1996
; Paulusma
et al., 1996
; Schaub et al.,
1997
). However, the functional identification of an
ATP-dependent organic anion transporter in membrane vesicles from renal
proximal tubular cells, such as in liver canalicular membranes, has
never been documented (Pritchard and Miller, 1993
). This is mainly due
to technical limitations because membrane vesicles of renal proximal
tubular cells are exclusively orientated right-side out (Haase et
al., 1978
). Recently, Masereeuw et al.
(1996)
identified an energy-dependent transport mechanism
for organic anions in isolated renal proximal tubules from killifish
using FL-MTX as a substrate. The excretory pathway of FL-MTX was
characteristic for its sensitivity to LTC4, MTX,
CsA, and probenecid. In addition, the energy-dependency of this pathway
was confirmed by treating cells with KCN, which did not influence
FL-MTX uptake but completely abolished luminal excretion. This suggests
that FL-MTX may be an Mrp2-substrate for which we provide evidence in
this study because FL-MTX strongly inhibits
[3H]E217
G uptake in
Sf9-Mrp2 membrane vesicles. In contrast, FL did not inhibit
[3H]E217
G uptake,
whereas MTX was only partially inhibitory. It remains to be established
whether Mrp2 directly mediates ATP-dependent uptake of FL-MTX.
Besides Mrp2, additional organic anion transporters might be present in
brush-border membranes of renal proximal tubular cells. For example,
excretion of FL-MTX was shown to be only partially inhibited by
probenecid, whereas the probenecid-insensitive mechanism was inhibited
completely by verapamil (Masereeuw et al., 1996
). In addition, it has been shown that TR
rats
have impaired hepatic excretion of the conjugates
-naphthyl-
-D-glucuronide and
LTC4, whereas urinary excretion is hardly
affected (Huber et al., 1987
; de Vries et
al., 1989
), suggesting that the deficiency of Mrp2 in
the kidney can be compensated for by other organic anion transporters.
Possible candidates might be the organic anion transporters Oatp1 and
Oat-k1, which are both localized in brush-border membranes of renal
proximal tubular cells (Bergwerk et al., 1996
; Masuda et al., 1997
). Although Oatp1 and Oat-k1
are structurally not related to Mrp2, these proteins mediate transport
of Mrp2-substrates, such as E217
G,
LTC4, and MTX (Kanai et al.,
1996
; Saito et al., 1996
; Li et
al., 1997
). Furthermore, the recently identified family members of human MRP1 (i.e., MRP3, MRP4, and MRP5) are all expressed to
some extent in the kidney and might also be involved in renal organic
anion transport (Kool et al., 1997
).
In conclusion, we demonstrated ATP-dependent transport by recombinant rabbit Mrp2 and provided new data on inhibitor specificity. In future studies, this expression system will be used for identification and characterization of Mrp2-substrates, with emphasis on compounds that are excreted by the kidney.
| |
Acknowledgments |
|---|
We thank A. Hartog for isolation of cells of rabbit renal proximal tubules. We also thank Drs. J. Renes and M. Müller (Division of Gastroenterology and Hepatology, University Hospital Groningen, The Netherlands) for stimulating discussions and suggestions for improving the vesicular transport assay.
| |
Footnotes |
|---|
Received January 2, 1998; Accepted March 10, 1998
This work was supported in part by the Netherlands Organization for Scientific Research through Grants 805-05.041 (J.B.K.) and 900.522.132 (M.A. van K.). P.M.T.D. is an investigator of the Royal Netherlands Academy of Arts and Sciences.
Send reprint requests to: Dr. F. G. M. Russel, University of Nijmegen, Department of Pharmacology 233, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: f.russel{at}farm.kun.nl
| |
Abbreviations |
|---|
MRP2, multidrug resistance-associated
protein 2;
cMOAT, canalicular multispecific organic anion transporter;
TR
, transport-deficient rat;
EHBR, Eisai
hyperbilirubinemic rat;
MRP1, multidrug resistance-associated protein
1;
ABC, ATP-binding cassette;
CFTR, cystic fibrosis transmembrane
conductance regulator;
LTC4, leukotriene C4;
E217
G, 17
-estradiol-17-
-D-glucuronide;
FL, fluorescein;
MTX, methotrexate;
FL-MTX, fluorescein methotrexate;
CsA, cyclosporin A;
MK571, 3-([{3-(2-[7-chloro-2-quinolinyl]ethenyl)phenyl}-{(3-dimethyl-amino-3-oxopropyl)-thio}-methyl]thio)propanoic
acid .
| |
References |
|---|
|
|
|---|
-estradiol 17-(
-D-glucuronide) in rat canalicular membrane vesicles.
Am J Physiol
271:
G791-G798This article has been cited by other articles:
![]() |
R. M. Pelis, M. Shahidullah, S. Ghosh, M. Coca-Prados, S. H. Wright, and N. A. Delamere Localization of Multidrug Resistance-Associated Protein 2 in the Nonpigmented Ciliary Epithelium of the Eye J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Miller, J. R. Shaw, C. R. Stanton, R. Barnaby, K. H. Karlson, J. W. Hamilton, and B. A. Stanton MRP2 and Acquired Tolerance to Inorganic Arsenic in the Kidney of Killifish (Fundulus heteroclitus) Toxicol. Sci., May 1, 2007; 97(1): 103 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gerk, W. Li, V. Megaraj, and M. Vore Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 893 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wever, R. Masereeuw, D. S. Miller, X. M. Hang, and G. Flik Endothelin and calciotropic hormones share regulatory pathways in multidrug resistance protein 2-mediated transport Am J Physiol Renal Physiol, January 1, 2007; 292(1): F38 - F46. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Leader and M. J. O'Donnell Transepithelial transport of fluorescent p-glycoprotein and MRP2 substrates by insect Malpighian tubules: confocal microscopic analysis of secreted fluid droplets J. Exp. Biol., December 1, 2005; 208(23): 4363 - 4376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Notenboom, D. S. Miller, L. H. Kuik, P. Smits, F. G. M. Russel, and R. Masereeuw Short-Term Exposure of Renal Proximal Tubules to Gentamicin Increases Long-Term Multidrug Resistance Protein 2 (Abcc2) Transport Function and Reduces Nephrotoxicant Sensitivity J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 912 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, X. Tian, P. Chandra, and K. L. R. Brouwer Role of Glycosylation in Trafficking of Mrp2 in Sandwich-Cultured Rat Hepatocytes Mol. Pharmacol., April 1, 2005; 67(4): 1334 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ninomiya, K. Ito, and T. Horie FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2 Drug Metab. Dispos., February 1, 2005; 33(2): 225 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, P. H. E. Smeets, J. J. M. W. van den Heuvel, and F. G. M. Russel Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites Am J Physiol Renal Physiol, February 1, 2005; 288(2): F327 - F333. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kunta, S.-H. Lee, B. A. Perry, Y.-H. Lee, and P. J. Sinko DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS Drug Metab. Dispos., November 1, 2004; 32(11): 1293 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H.E. Smeets, R. A.M.H. van Aubel, A. C. Wouterse, J. J.M.W. van den Heuvel, and F. G.M. Russel Contribution of Multidrug Resistance Protein 2 (MRP2/ABCC2) to the Renal Excretion of p-aminohippurate (PAH) and Identification of MRP4 (ABCC4) as a Novel PAH Transporter J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2828 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Masereeuw, S. Notenboom, P. H. E. Smeets, A. C. Wouterse, and F. G. M. Russel Impaired Renal Secretion of Substrates for the Multidrug Resistance Protein 2 in Mutant Transport-Deficient (TR-) Rats J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2741 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li, K. Ito, and T. Horie Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G602 - G610. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Williams, A. Liu, G. Knipp, and P. J. Sinko Direct Evidence that Saquinavir Is Transported by Multidrug Resistance-Associated Protein (MRP1) and Canalicular Multispecific Organic Anion Transporter (MRP2) Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3456 - 3462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Chen, K. Lee, S. Walther, R. B. Raftogianis, M. Kuwano, H. Zeng, and G. D. Kruh Analysis of Methotrexate and Folate Transport by Multidrug Resistance Protein 4 (ABCC4): MRP4 Is a Component of the Methotrexate Efflux System Cancer Res., June 1, 2002; 62(11): 3144 - 3150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Terlouw, C. Graeff, P. H. E. Smeets, G. Fricker, F. G. M. Russel, R. Masereeuw, and D. S. Miller Short- and Long-Term Influences of Heavy Metals on Anionic Drug Efflux from Renal Proximal Tubule J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. van Aubel, P. H. E. Smeets, J. G. P. Peters, R. J. M. Bindels, and F. G. M. Russel The MRP4/ABCC4 Gene Encodes a Novel Apical Organic Anion Transporter in Human Kidney Proximal Tubules: Putative Efflux Pump for Urinary cAMP and cGMP J. Am. Soc. Nephrol., March 1, 2002; 13(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Cherrington, D. P. Hartley, N. Li, D. R. Johnson, and C. D. Klaassen Organ Distribution of Multidrug Resistance Proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and Hepatic Induction of Mrp3 by Constitutive Androstane Receptor Activators in Rats J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 97 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Miller, C. Graeff, L. Droulle, S. Fricker, and G. Fricker Xenobiotic efflux pumps in isolated fish brain capillaries Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R191 - R198. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Terlouw, R. Masereeuw, F. G. M. Russel, and D. S. Miller Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux Mol. Pharmacol., June 1, 2001; 59(6): 1433 - 1440. [Abstract] [Full Text] |
||||
![]() |
K. Ito, H. Suzuki, and Y. Sugiyama Charged Amino Acids in the Transmembrane Domains Are Involved in the Determination of the Substrate Specificity of Rat Mrp2 Mol. Pharmacol., April 16, 2001; 59(5): 1077 - 1085. [Abstract] [Full Text] |
||||
![]() |
D. S. Miller, S. N. Nobmann, H. Gutmann, M. Toeroek, J. Drewe, and G. Fricker Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy Mol. Pharmacol., April 13, 2001; 58(6): 1357 - 1367. [Abstract] [Full Text] |
||||
![]() |
K. Lee, A. J. P. Klein-Szanto, and G. D. Kruh Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells J Natl Cancer Inst, December 6, 2000; 92(23): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shuprisha, S. H. Wright, and W. H. Dantzler Method for measuring luminal efflux of fluorescent organic compounds in isolated, perfused renal tubules Am J Physiol Renal Physiol, November 1, 2000; 279(5): F960 - F964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. M. H. Van Aubel, J. G. P. Peters, R. Masereeuw, C. H. Van Os, and F. G. M. Russel Multidrug resistance protein Mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate Am J Physiol Renal Physiol, October 1, 2000; 279(4): F713 - F717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zeng, G. Liu, P. A. Rea, and G. D. Kruh Transport of Amphipathic Anions by Human Multidrug Resistance Protein 3 Cancer Res., September 1, 2000; 60(17): 4779 - 4784. [Abstract] [Full Text] |
||||
![]() |
R. A. M. H. Van Aubel, R. Masereeuw, and F. G. M. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Renal Physiol, August 1, 2000; 279(2): F216 - F232. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bakos, R. Evers, E. Sinkó, A. Váradi, P. Borst, and B. Sarkadi Interactions of the Human Multidrug Resistance Proteins MRP1 and MRP2 with Organic Anions Mol. Pharmacol., April 1, 2000; 57(4): 760 - 768. [Abstract] [Full Text] |
||||
![]() |
T. Hirohashi, H. Suzuki, H. Takikawa, and Y. Sugiyama ATP-dependent Transport of Bile Salts by Rat Multidrug Resistance-associated Protein 3 (Mrp3) J. Biol. Chem., January 28, 2000; 275(4): 2905 - 2910. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirohashi, H. Suzuki, X.-Y. Chu, I. Tamai, A. Tsuji, and Y. Sugiyama Function and Expression of Multidrug Resistance-Associated Protein Family in Human Colon Adenocarcinoma Cells (Caco-2) J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 265 - 270. [Abstract] [Full Text] |
||||
![]() |
R. Masereeuw, S. A. Terlouw, R. A. M. H. van Aubel, F. G. M. Russel, and D. S. Miller Endothelin B Receptor-Mediated Regulation of ATP-Driven Drug Secretion in Renal Proximal Tubule Mol. Pharmacol., January 1, 2000; 57(1): 59 - 67. [Abstract] [Full Text] |
||||
![]() |
R. A. M. H. Van Aubel, J. B. Koenderink, J. G. P. Peters, C. H. Van Os, and F. G. M. Russel Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells Mol. Pharmacol., October 1, 1999; 56(4): 714 - 719. [Abstract] [Full Text] |
||||
![]() |
H. Ishizuka, K. Konno, T. Shiina, H. Naganuma, K. Nishimura, K. Ito, H. Suzuki, and Y. Sugiyama Species Differences in the Transport Activity for Organic Anions across the Bile Canalicular Membrane J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1324 - 1330. [Abstract] [Full Text] |
||||
![]() |
S. Jariyawat, T. Sekine, M. Takeda, N. Apiwattanakul, Y. Kanai, S. Sophasan, and H. Endou The Interaction and Transport of beta -Lactam Antibiotics with the Cloned Rat Renal Organic Anion Transporter 1 J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 672 - 677. [Abstract] [Full Text] |
||||
![]() |
T. Hirohashi, H. Suzuki, and Y. Sugiyama Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3) J. Biol. Chem., May 21, 1999; 274(21): 15181 - 15185. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, J. König, U. Buchholz, H. Spring, I. Leier, and D. Keppler Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells Mol. Pharmacol., May 1, 1999; 55(5): 929 - 937. [Abstract] [Full Text] |
||||
![]() |
X.-Y. Chu, H. Suzuki, K. Ueda, Y. Kato, S.-I. Akiyama, and Y. Sugiyama Active Efflux of CPT-11 and Its Metabolites in Human KB-Derived Cell Lines J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 735 - 741. [Abstract] [Full Text] |
||||
![]() |
Correction for vol. 93, p. 5401 PNAS, September 29, 1998; 95(20): 12070 - 12070. [Full Text] [PDF] |
||||
![]() |
Z.-S. Chen, K. Lee, and G. D. Kruh Transport of Cyclic Nucleotides and Estradiol 17-beta -D-Glucuronide by Multidrug Resistance Protein 4. RESISTANCE TO 6-MERCAPTOPURINE AND 6-THIOGUANINE J. Biol. Chem., August 31, 2001; 276(36): 33747 - 33754. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Ito, C. J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. C. Cole Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity J. Biol. Chem., October 5, 2001; 276(41): 38108 - 38114. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||